Literature DB >> 17312442

Contrast-enhanced cardiac magnetic resonance in a patient with chemotoxic cardiomyopathy.

Oronzo Catalano1, Serena Antonaci, Guido Moro, Maurizia Baldi, Franco Cobelli, Cristina Opasich.   

Abstract

Gadolinium-enhanced cardiac magnetic resonance was performed in a patient with chemotoxic cardiomyopathy. Intramyocardial midwall linear delayed hyperenhancement was found. Such a finding is consistent with midwall fibrosis and/or myocardial cell loss due to cardiotoxic effect of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17312442     DOI: 10.2459/JCM.0b013e3280104155

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  1 in total

1.  Mid wall fibrosis on CMR with late gadolinium enhancement may predict prognosis for LVAD and transplantation risk in patients with newly diagnosed dilated cardiomyopathy-preliminary observations from a high-volume transplant centre.

Authors:  Jose V Venero; Mark Doyle; Moneal Shah; Vikas K Rathi; June A Yamrozik; Ronald B Williams; Diane A Vido; Geetha Rayarao; Raymond Benza; Srinivas Murali; Jerry Glass; Peter Olson; George Sokos; Robert W W Biederman
Journal:  ESC Heart Fail       Date:  2015-07-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.